Alx Oncology Holdings Inc (ALXO)

May 18, 2026

Is ALX Oncology Holdings (ALXO) outperforming other medical stocks this year? - MSN

May 18, 2026

May 18, 2026

ALXO Stock Price, Quote & Chart | ALX ONCOLOGY HOLDINGS INC (NASDAQ:ALXO) - ChartMill

May 18, 2026

May 15, 2026

Redmile Group, ALXO: Investment manager discloses 6.8% ownership - Stock Titan

May 15, 2026

May 15, 2026

HBM Healthcare (ALXO) discloses 8.59M shares, ~6.5% stake - Stock Titan

May 15, 2026

May 14, 2026

Earnings call transcript: ALX Oncology beats Q1 2026 earnings forecast - Investing.com

May 14, 2026

May 13, 2026

Q2 EPS Estimates for ALX Oncology Raised by HC Wainwright - MarketBeat

May 13, 2026

May 12, 2026

TradingKey - TradingKey

May 12, 2026

May 12, 2026

UBS Maintains ALX Oncology(ALXO.US) With Buy Rating, Maintains Target Price $6 - Moomoo

May 12, 2026

May 12, 2026

Is ALX Oncology Holdings (ALXO) Outperforming Other Medical Stocks This Year? - Yahoo Finance

May 12, 2026

May 12, 2026

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Q1 2026 Earnings Call Transcript - Insider Monkey

May 12, 2026

May 11, 2026

Alx Oncology Signals Promise, But Validation Looms - TipRanks

May 11, 2026

May 11, 2026

ALX Oncology outlines interim ASPEN-09 data from ~80 patients by mid-2027 as CD47-high cohort shows 22-month median PFS - MSN

May 11, 2026

May 11, 2026

H.C. Wainwright Maintains ALX Oncology(ALXO.US) With Buy Rating, Maintains Target Price $4 - Moomoo

May 11, 2026

May 11, 2026

Piper Sandler Maintains ALX Oncology(ALXO.US) With Buy Rating, Maintains Target Price $4 - Moomoo

May 11, 2026

May 11, 2026

ALX ONCOLOGY ($ALXO) Releases Q4 2025 Earnings - Moomoo

May 11, 2026

May 09, 2026

ALX Oncology Holdings Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 09, 2026

May 09, 2026

ALXO: ALX Oncology Reports Promising Data on CD47 Biomarker in H - GuruFocus

May 09, 2026

May 09, 2026

ALX Oncology Holdings Inc. Q1 2026 Earnings Call Summary - Yahoo Finance

May 09, 2026

May 09, 2026

ALX ONCOLOGY ($ALXO) Releases Q1 2026 Earnings - Moomoo

May 09, 2026

May 08, 2026

ALX Oncology Holdings Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:ALXO) 2026-05-08 - Seeking Alpha

May 08, 2026

May 08, 2026

ALX Oncology Q1 Earnings Call Highlights - Barchart.com

May 08, 2026

May 08, 2026

Earnings call transcript: ALX Oncology Q1 2026 reveals clinical progress By Investing.com - Investing.com Canada

May 08, 2026

May 08, 2026

ALX Oncology Reports First Quarter 2026 Financial Results and Provides Corporate Update - Investing News Network

May 08, 2026

May 08, 2026

ALX Oncology 1Q Loss/Shr 17c >ALXO - Moomoo

May 08, 2026

May 08, 2026

ALX Oncology Holdings Inc (NASDAQ:ALXO) Beats Q1 Estimates and Unveils Promising Breast Cancer Data - ChartMill

May 08, 2026

May 08, 2026

ALX Oncology Q1 2026 Earnings Call Transcript - MarketBeat

May 08, 2026

May 08, 2026

ALX Oncology Holdings 1Q 2026: Net income $(17.9M), EPS $(0.17) — 10-Q Summary - TradingView

May 08, 2026

May 08, 2026

[10-Q] ALX ONCOLOGY HOLDINGS INC Quarterly Earnings Report - Stock Titan

May 08, 2026

May 08, 2026

ALX Oncology reports Q1 net loss of $17.9M, cash $169.1M; advances evorpacept and ALX2004 programs - TradingView

May 08, 2026

May 08, 2026

ALXO: Durable clinical responses and reduced net loss highlight progress in HER2-positive cancer trials - TradingView

May 08, 2026

May 08, 2026

ALX Oncology Holdings Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 08, 2026

May 08, 2026

ALX Oncology (NASDAQ: ALXO) cuts Q1 loss, raises $150M for cancer pipeline - Stock Titan

May 08, 2026

May 08, 2026

ALX Oncology reports all 5 high-CD47 breast cancer patients responded - Stock Titan

May 08, 2026

May 07, 2026

ALX Oncology reports breast cancer trial data with CD47 biomarker - Investing.com UK

May 07, 2026

May 07, 2026

MSN Money - MSN

May 07, 2026

May 07, 2026

ALX Oncology's Evorpacept in Combination with Zanidatamab Generates Promising, Durable Response in Patients with Advanced HER2-Positive Breast Cancer and High CD47 Expression - Investing News Network

May 07, 2026

May 07, 2026

ALX Oncology reports breast cancer trial data with CD47 biomarker By Investing.com - Investing.com Australia

May 07, 2026

May 07, 2026

Insiders Buying ALX Oncology Holdings Might Wish They Invested More, Stock Gains 32% - Moomoo

May 07, 2026

May 07, 2026

Alx Oncology's evorpacept in combination with zanidatamab generates promising, durable response in patients with advanced her2-positive breast cancer and high cd47 expression - marketscreener.com

May 07, 2026

May 07, 2026

ALX Oncology’s Evorpacept in Combination with Zanidatamab Generates Promising, Durable Response in Patients with Advanced HER2-Positive Breast Cancer and High CD47 Expression - The Manila Times

May 07, 2026

May 07, 2026

In ALX breast cancer study, 5 of 5 high-CD47 patients responded - Stock Titan

May 07, 2026

May 07, 2026

ALX Oncology’s Evorpacept in Combination with Zanidatamab - GlobeNewswire

May 07, 2026

May 06, 2026

ALX Oncology Holdings Inc expected to post a loss of 22 cents a shareEarnings Preview - TradingView

May 06, 2026

May 05, 2026

ALXO SEC FilingsAlx Oncology Holdings Inc 10-K, 10-Q, 8-K Forms - Stock Titan

May 05, 2026

May 04, 2026

ALX Oncology (ALXO.US) will release its earnings report before the market opens on May 8. - Moomoo

May 04, 2026

May 04, 2026

ALXO Stock Chart | ALX ONCOLOGY HOLDINGS INC (NASDAQ:ALXO) - ChartMill

May 04, 2026

May 02, 2026

Favourable Signals For ALX Oncology Holdings: Numerous Insiders Acquired Stock - Yahoo Finance

May 02, 2026